NEOCRTEC5010-LONG-TERM
Regimen
- Experimental
- neoadjuvant vinorelbine/cisplatin + 40 Gy RT + surgery
- Control
- surgery alone
Population
Thoracic ESCC clinical stage T1-4N1M0 or T4N0M0, long-term follow-up
Key finding
5y OS 59.9% vs 49.1% (HR 0.74, P=.03); 5y DFS 63.6% vs 43.0% (HR 0.60).
Source: PMID 34160577